Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer

This phase II study investigated dose-intense erlotinib maintenance after dose-dense chemotherapy for patients with metastatic non-small cell lung cancer and examined two cell cycle biomarkers. Patients with newly diagnosed metastatic non-small cell lung cancer received docetaxel 75 mg/m(2) and cisp...

Descripción completa

Detalles Bibliográficos
Autores principales: PETTY, W. JEFFREY, LAUDADIO, JENNIFER, BRAUTNICK, LYNSAY, LOVATO, JAMES, DOTSON, TRAVIS, STREER, NATHAN P., WEAVER, KATHRYN E., MILLER, ANTONIUS A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981037/
https://www.ncbi.nlm.nih.gov/pubmed/24100924
http://dx.doi.org/10.3892/ijo.2013.2122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981037/
https://www.ncbi.nlm.nih.gov/pubmed/24100924
http://dx.doi.org/10.3892/ijo.2013.2122

Ejemplares similares